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 Cutaneous leishmaniasis (CL) is the commonest form of 
leishmaniasis and has an estimated 1.5 million infections annu-
ally worldwide. 1 This disease predominantly occurs in persons 
living in disease-endemic countries but also is an increas-
ing problem in travelers. The Hospital for Tropical Diseases 
in London provides tertiary level clinical care for patients 
with imported CL, and hosts the United Kingdom Health 
Protection Agency Reference Laboratory for Parasitology. 
 Cutaneous leishmaniasis is categorized into Old World 
CL and New World CL. Differentiation is important because 
mucosal disease (ML) is caused by New World CL, specifically 
 Leishmania ( Viannia ) spp. and requires systemic treatment. 2 
Skin lesions are classically ulcerated, but may be nodular or 
keratotic. 
 Endemic CL is caused by  L. infantum in Spain and Portugal; 3 
 L. infantum ,  L. major , and  L. tropica in Cyprus and Turkey; 4, 5 
by  L. major and  L. tropica in Iran, India, and Pakistan; 6– 8 and 
by  L. aethiopica, L. major , and  L. infantum in Ethiopia and 
Saharan Africa. 9– 11  L. ( Viannia ) spp. is the predominant cause 
of New World throughout Central and South America. 12 
 Non-healing skin lesions in a patient with an appropriate 
travel history referred to the Hospital for Tropical Diseases 
undergo a skin biopsy, of which a sample is examined for 
 Leishmania spp. by microscopy, histologic analysis, and cul-
ture. The sensitivity of these investigations ranges from 33% 
to 74%. 13, 14 The polymerase chain reaction (PCR), which has 
been used to detect  Leishmania DNA, has improved diagnos-
tic sensitivity to 95%. 13 The Hospital for Tropical Diseases has 
used PCR for diagnostic DNA detection in all suspected cases 
of CL since 1996. 
 The purpose of this study was to use the large comprehen-
sive Hospital for Tropical Diseases clinical database of all lab-
oratory-proven cases of leishmaniasis over an 11-year period 
(1998–2009). Our main objective was to report the epidemiol-
ogy of imported CL, correlations of the type of traveler with 
the country of travel, and the species of  Leishmania acquired. 
We looked for regional correlations between species known 
to cause local endemic disease and those species acquired by 
travelers ( Tables 2 and 3 ). 
 Clinical details were obtained from case notes when the lab-
oratory recorded a positive result for  Leishmania spp. Data 
obtained included type of traveler, country of travel, time to 
referral, diagnostic tests performed, and  Leishmania species. 
 The laboratory received fresh and fixed specimens. A dab 
preparation was made from the fresh specimens and stained 
with Giemsa or modified Rapid Field stain and inspected 
microscopically for amastigotes. Fresh material was also inocu-
lated into modified Novy-Nicolle-McNeil medium and growth 
was checked weekly for 14–21 days. The time from the sam-
ple being received by the laboratory to confirming the diag-
nosis of infection with  Leishmania spp. by any modality was 
recorded.  Leishmania DNA was extracted, and amplification 
was attempted by using PCR on all samples from cases of sus-
pected leishmaniasis. 
 All extractions were performed by using the Qiagen Tissue 
and Blood Mini Kit (Qiagen, Crawley, United Kingdom). 
Histologic sections were de-waxed by using xylene and abso-
lute ethanol before extraction. During the study, primer sets 
were changed and the repertoire increased, as shown in the 
algorithm in  Figure 1 , because more species-specific primers 
became available. 
 The most sensitive PCR (nested) used in species identifica-
tion for most cases uses kinetoplast minicircle DNA. 15, 16 The 
PCR products were subjected to electrophoresis on agarose 
gels containing ethidium bromide, and diagnosis and species 
identification was performed by comparison with a molecular 
mass standard and amplified DNA from control strains. 
 A total of 223 patients were given a diagnosis of CL 
during 1998–2009. Of these patients, 133 were given a diag-
nosis of New World CL and 90 were given a diagnosis of Old 
World CL ( Table 1 ). More males than females were infected 
(67% with Old World CL versus 67% with New World CL 70%), 
and the median age was 26.5 years. The median time from 
lesion onset to definitive diagnosis was five months for 
patients with Old World CL (range = < 1–35 months) and 
two months for patients with New World CL (range = 
< 1–24 months). Tourists (32%) and migrants either  entering 
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the United Kingdom or visiting friends and relatives in a 
disease-endemic country (36%) predominated in the Old 
World CL group. Twenty-five tourists acquired Old World CL 
in the Mediterranean basin, particularly in Spain (11 of 25, 
44%). All military personnel acquired their disease in Iraq or 
Afghanistan. 
 New World CL occurred mainly in travelers on backpack-
ing trips (44%) and in soldiers (29%) performing jungle train-
ing in Belize. There were 11 cases of ML in patients with New 
World CL; all were caused by  L. ( Viannia ) spp. ( Table 1 ). 
 Countries of acquisition of Old World CL are shown in 
 Table 2 . The commonest region was the Mediterranean; 
this region had 20 cases caused by the  L. donovani complex 
(the Hospital for Tropical Diseases PCR cannot distinguish 
between the DNA of  L. donovani and  L. infantum ).  Leishmania 
was the predominant species and caused Old World CL in 
Afghanistan, Pakistan, and Iraq (n = 18).  Leishmania major 
caused Old World CL in Pakistan, Iraq, Afghanistan, and 
Africa (n = 19). 
 Countries of acquisition for New World CL are shown in 
 Table 3 . Of 133 cases, country of acquisition was available for 
127 travelers. Eighty-one had traveled to Central America and 
46 to South America.  Leushmania ( Viannia ) spp. caused 97 
(86%) cases of New World CL and was associated with travel 
to Central America (n = 56) and South America (n = 41). 
 Leishmania mexicana was detected in 26 (32%) cases associ-
ated with Central America, particularly Belize; only one case 
was acquired in South America. There were three cases of 
infection with  L. amazonensis , all of which were acquired in 
South America. 
 For Old World CL, sensitivity was 86% for the PCR, 52% 
for culture, and 62% for microscopy. The sensitivity of tests 
for NWCL was 96% for PCR, 68% for culture and 77% for 
microscopy ( Table 4 ). Because positive results for histologic 
samples were not fully recorded in the database, these data are 
not reported. The mean time to a positive diagnosis by PCR 
was 8 days and to any result either positive or negative by cul-
ture was 11.6 days (n = 134) ( P < 0.005, by paired two-tailed 
 t -test). 
 Figure 1.  Algorithm for diagnosis of  Leishmania infection by polymerase chain reaction, Hospital for Tropical Diseases, London, United 
Kingdom. 
 Table 1 
 Demographic characteristics of study population, Hospital for Tropical 
Diseases, London, United Kingdom * 
Characteristic
Old World 
CL † 
Range or 
%
New World 
CL † 
Range or 
%
Total 90 133
Male sex 60 (67) 93 (70)
Median age at 
presentation, years 27 3–86 26 2–80
HIV infected ‡ 0/11 0/21
Median time to 
presentation, months 5 < 1–35 2 < 1–24
Mucosal involvement 0/90 11/133
Type of traveler
 Visiting friends and 
relatives/new entrant 33 36 2 1.5
 Tourist 29 32 7 5
 Soldier/military 15 17 39 29
 Backpacker/NGO 
worker 3 3 59 44
 Other (business, 
missionary) 8 9 24 18
 *  CL = cutaneous leishmaniasis; HIV = human immunodeficiency virus; NGO = non-
government organization. 
 † Values are no. (%) unless otherwise indicated. 
 ‡ Thirty-two persons were tested for HIV. 
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 This study is the largest case series of imported CL from 
a tertiary referral center in Europe. Data clearly show that 
different Old World CL  Leishmania species in travelers are 
found in distinct geographic areas. Endemic disease patterns 
correlate closely with travel-acquired CL, and identical spe-
cies cause disease in each region. 
 The large numbers of  L. donovani complex cases acquired 
in Spain and the Balearic Islands is probably associated with 
increasing numbers of British tourists traveling to Spain. A 
study from our institute (n = 42 over 3 years) showed that 
40% of patients with CL were tourists. 17 Other centers have 
reported similar trends for Old World CL and New World 
CL. 18, 19 Lawn and others at the Hospital for Tropical Diseases 
reported increasing numbers of imported cases of New World 
CL during 1999–2003 (79 CL and 6 ML), 20 which reflected 
increasing numbers of travelers at risk for acquiring CL rather 
than an overall increase in the disease. Infections acquired in 
the Near East/Middle East and Africa were in military per-
sonnel and persons visiting friends and relatives. Soldiers 
have been in Iraq and Afghanistan since 2001. The increase in 
cases in persons visiting friends and relatives may be caused 
by increasing numbers of migrants to the United Kingdom; 
soldiers caused the predominance of males in the Old World 
CL group. 
 The large number of case of New World CL seen in travel-
ers was unexpected. A study in the Netherlands reported 78 
patients seen over 10 years, of whom 78% had New World CL, 
but did not give detailed reasons for travel. 19 In our study, most 
cases of New World CL from this region were military person-
nel, (from the United Kingdom Government’s jungle training 
facility in Belize) and adventure tourists. Only two (1.5%) of 
our cases of New World CL were in immigrants/ persons visit-
ing friends and relatives compared with 36% in the Old World 
CL group. 
 As shown in other studies, 5, 15, 21 detection of  Leishmania 
DNA by using PCR is highly sensitive for the diagnosis of CL 
and identifies species. Specificity of PCR is also high. Previous 
work from our laboratory on smaller numbers of samples has 
shown a sensitivity of »100% for detection of  L. ( Viannia ) spp. 
DNA by using PCR. 17, 20,  22 This larger data set showed a defini-
tive sensitivity of PCR at the Hospital for Tropical Diseases of 
86% for Old World CL and 96% for New World CL. Diagnosis 
by using PCR significantly reduces the time to obtain a defini-
tive diagnosis and is the only technique yielding a species that 
can be used on fixed specimens. 
 Only 32 patients were tested for infection with human 
immunodeficiency virus; all had negative results. This finding 
contrasts with that for visceral leishmaniasis, for which infec-
tion with this virus is an established risk factor. Our study was 
restricted to demographic details that had been recorded in 
the case notes for most cases. Therefore, we were unable to 
obtain detailed information for some patients. 
 Polymerase chain reaction was performed for all specimens, 
but the date at which a negative PCR result is final was not 
routinely recorded. Therefore, we could only calculate the 
diagnosis times for cases with positive results, which led to 
potential bias. We also only included patients seen in our own 
unit. Therefore, our data are likely not to be completely repre-
sentative of all cases of CL in the United Kingdom. 
 Our study is the largest case series of imported CL reported 
in the literature. We have identified a range of different 
 Leishmania species in travelers, associated with particular 
demographic groups, who all acquired locally endemic disease. 
The use of PCR to detect  Leishmania DNA has improved the 
sensitivity and specificity of laboratory diagnosis. Use of this 
technique to identify species enables the treating clinician to 
select the most appropriate therapy and significantly reduces 
time to definitive diagnosis. 
 Table 2 
 Epidemiologic distribution of Old World  Leishmania spp. causing cutaneous leishmaniasis, Hospital for Tropical Diseases, London, United 
Kingdom 
Location  L. donovani  L. tropica  L. major  L. aethiopica Not speciated Total per country
Mediterranean (European countries bordering the Mediterranean 
Sea including Cyprus, Greece, Majorca, Malta and Gozo, 
Portugal, Spain and the Balearic Islands, and Sicily) 20 1 0 0 4 25
Near East (Jordan, Turkey, Syria, Yemen, and Israel) 4 3 5 0 5 17
Pakistan 2 6 1 0 1 10
Afghanistan 2 9 2 0 6 19
Africa (Continental Africa including all countries 
bordering the Sahara) 0 0 3 1 2 6
India 0 0 0 0 1 1
Iraq 0 0 8 0 4 12
Total 28 19 19 1 23
 Table 3 
 Epidemiologic distribution of New World  Leishmania spp. causing cutaneous leishmaniasis, Hospital for Tropical Diseases, London, United 
Kingdom 
Location  L. ( Viannia ) spp.  L. mexicana  L. amazonensis Total per country
Belize 38 18 0 56
Bolivia 19 1 0 20
Peru 11 0 0 11
Central America (excluding Belize and the northern border 
of Mexico to the northern border of Colombia) 18 7 0 25
South America (excluding Bolivia or Peru) 11 1 3 15
Total 97 27 3 127
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